Alterations of sleep are reported to occur in sudden infant death syndrome (SIDS). It is well established that the hypothalamus mediates the onset, maintenance, and timing of sleep, and does so via serotonergic and cholinergic mechanisms.
We have investigated serotonergic and cholinergic synaptic markers in the hypothalamus from eight SIDS infants and six age-matched non-SIDS infants between 3 and 7 months of age. By use of established methods, we observed a number of chemical alterations in SIDS hypothalamus: (1) tryptophan content was increased and serotonin content was decreased, (2) serotonin binding was increased and imipramine binding was unchanged, (3) monoamine oxidase-A activity was increased without an effect on monoamine oxidase-B, and (4) choline acetyltransferase activity was decreased and acetylcholinesterase activity was unchanged. (J Child Neurol 1991;6:335-339).
Get full access to this article
View all access options for this article.
References
1.
Valdes-Dapena M.: Sudden infant death syndrome: Overview of recent research developments from a pediatric pathologist's perspective. Pediatrician1988;15:222-230.
2.
Naeye RL: Hypoxemia and the sudden infant death syndrome. Science1974;186:837-838.
3.
Aranda JV, Trippenbach T., Turmen T., Lopes JM: Apnea and control of breathing in newborn infants, in Diagnosis and Management of Respiratory Disorders in the Newborn. Addison-Wesley, 1982, pp 134-157.
4.
Korner AF, Guilleminault C., Van den Hoed J., Baldwin RB: Reduction of sleep apnea and bradycardia in preterm infants on oscillating water beds: A controlled polygraphic study. Pediatrics1978;61:528-533.
5.
Kattwinkel J. : Neonatal apnea: Pathogenesis and therapy. J Pediatr1977;90:342-347.
6.
Cherniack NS : Sleep apnea and its causes. J Clin Invest1984; 73:1501-1506.
7.
Lacey DJ: Sleep EEG abnormalities in children with near-miss sudden infant death syndrome, in siblings, and in infants with recurrent apnea. J Pediatr1983;102:855-859.
8.
Wantanabe K. , Inokuma K., Negro T.: REM sleep prevents sudden infant death syndrome . Eur J Pediatr1983;140:289-292.
9.
Steinschneider AS, Weinstein SL, Diamond E.: Sudden infant death syndrome and apnea/obstruction during neonatal sleep and feeding. Pediatrics1982;70:858-863.
10.
Jouvet M.: Neuropharmacology of the sleep-waking cycle, in Iversen I, Lars L, Iversen S (eds): Handbook ofPsychopharmacology, Vol 8. 1977 , pp 233-293.
11.
Jouvet M.: The role of monoamines and acetylcholine-containing neurons in the regulation of the sleep-waking cycle. Ergeb Physiol1972 ;64:165-305.
12.
Kircher T., Anderson R.: Cause of Death: Proper completion of the death certificate. JAMA1988;258:349-352.
Sparks DL, Slevin JT: Determination of tyrosine, tryptophan and their metabolic derivatives by liquid chromatography-electrochemical detection: Application to postmortem samples from patients with Parkinson's and Alzheimer's disease. Life Sci1985;36:449-457.
15.
Rehavi M., Paul SM, Skolnick P., Goodwin FK: Demonstration of specific high affinity binding sites for [3 H]-imipramine in human brain. Life Sci1980;26:2273-2279.
16.
Nelson DL, Herbert A., Bourgoin S., et al: Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat. Mol Pharmacol1978;14:983-995.
17.
Fonnum FJ: Radiochemical microassay for the determination of choline acetyltransferase and acetylcholinesterase activities. Biochem J1969;115:465-472.
18.
Ellman GL, Courtney KD, Andres V., et al: A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol1961;7:88-95.
19.
Sparks DL, Buckholtz NS: Combined inhibition of serotonin uptake and oxidative deamination attenuates audiogenic seizures in DBA/2J mice. Pharmacol Biochem Behav1985;23: 753-757.
20.
Wurtman RJ, Axelrod J.: A sensitive and specific assay for the estimation of monoamine oxidase . Biochem Pharmacol1963;12:1439-1441.
21.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem1951;193:263-274.
22.
Filiano JJ, Rubin DE, Simons JE, Kinney HC: Computer-reconstructed atlas of the human infant medulla and its raphe, abstract . J Neuropathol Exp Neurol1987;46:360.
23.
Kish S., Karlinsky H., Becker L., et al: Down's syndrome individuals begin life with normal levels of brain cholinergic markers. J Neurochem1989 ;52:1183-1187.
24.
Maurizi CP: Could supplementary dietary tryptophan prevent sudden infant death syndrome?Med Hypotheses1985;17:149-154.
25.
Sparks DL, Hunsaker JC: The pineal gland in sudden infant death syndrome: Preliminary observations . J Pineal Res1988;5:111-118.
26.
Sparks DL, Hunsaker JC: SIDS and the third eye: II. European Pineal Study Group, abstract . Guilford, Surrey, UK, 1990.
27.
Anton-Tay F. : Melatonin: Effects on brain function. Adv Biochem Psychopharmacol1974;11:315-324.
28.
Lang U., Aubert ML, Sizonenko PC: Location of melatonin receptors, abstract. Pediatr Res1981;15:80.
29.
Maurizi CP: A mechanism of mania and the chemistry of dreams: A hypothesis. South Med J1984;77:1491-1493.
30.
Sparks DL, Hunsaker JC: Increased ALZ-50-reactive neurons in the brains of SIDS infants: An indicator of greater neuronal death?J Child Neurol1991; 6:123-127.
